A vaccine for COVID-19 may be ready for emergency use by September 2022, Pfizer, an American biopharmaceutical company has said.
Pfizer stated on Tuesday that it will begin testing of the experimental vaccine in the US next week.
Worldometer reports that confirmed cases of COVID-19 globally have risen to 3,150,478, with 218,466 deaths — 964,161 recoveries.
The pharmaceutical company said the vaccine would be tested in the US after the human trials in Germany.
The World Health Organisation (WHO) has also stated that there are about 20 different potential COVID-19 vaccines currently in development.
Some of the companies working on a vaccine said they are accelerating the timeline for testing as experts predict that the COVID-19 pandemic may last till 2022.
- COVID-19 Vaccine To Be Available By September: Pfizer
- Bill Gates says Pfizer has best shot at early COVID-19 vaccine
- Rutgers to enroll 200 kids to take part in Pfizer COVID vaccine trial
- Pfizer, BioNTech dose first participants in COVID-19 vaccine trial
- Feds order 100 million doses of Pfizer’s COVID-19 vaccine for $2 billion
- NY expects 170K doses of Pfizer’s COVID-19 vaccine by mid-December
- These ultra-cold freezers will store Pfizer’s COVID-19 vaccine in NY
- Queens nurse becomes first in US, New York to get Pfizer’s COVID-19 vaccine
- Queens nurse becomes first in US to get Pfizer’s COVID-19 vaccine
- Pfizer CEO Albert Bourla explains why he hasnât taken COVID-19 vaccine yet